115 related articles for article (PubMed ID: 9657356)
41. Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis.
Papadopoulos V; Amri H; Boujrad N; Cascio C; Culty M; Garnier M; Hardwick M; Li H; Vidic B; Brown AS; Reversa JL; Bernassau JM; Drieu K
Steroids; 1997 Jan; 62(1):21-8. PubMed ID: 9029710
[TBL] [Abstract][Full Text] [Related]
42. Serum miRNA-27a and miRNA-18b as potential predictive biomarkers of hepatitis C virus-associated hepatocellular carcinoma.
Rashad NM; El-Shal AS; Shalaby SM; Mohamed SY
Mol Cell Biochem; 2018 Oct; 447(1-2):125-136. PubMed ID: 29455432
[TBL] [Abstract][Full Text] [Related]
43. Angiopoietin-like protein 3 and 4 expression 4 and their serum levels in hepatocellular carcinoma.
El-Shal AS; Zidan HE; Rashad NM; Wadea FM
Cytokine; 2017 Aug; 96():75-86. PubMed ID: 28371666
[TBL] [Abstract][Full Text] [Related]
44. Laparoscopic liver resections for hepatocellular carcinoma. Can we extend the surgical indication in cirrhotic patients?
Cipriani F; Fantini C; Ratti F; Lauro R; Tranchart H; Halls M; Scuderi V; Barkhatov L; Edwin B; Troisi RI; Dagher I; Reggiani P; Belli G; Aldrighetti L; Abu Hilal M
Surg Endosc; 2018 Feb; 32(2):617-626. PubMed ID: 28717870
[TBL] [Abstract][Full Text] [Related]
45. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy.
Pompili M; Rapaccini GL; Covino M; Pignataro G; Caturelli E; Siena DA; Villani MR; Cedrone A; Gasbarrini G
Cancer; 2001 Jul; 92(1):126-35. PubMed ID: 11443618
[TBL] [Abstract][Full Text] [Related]
46. Comparison of hepatocellular carcinoma with cirrhosis patients undergoing hepatic resection between hepatitis B and C infection.
Shiba H; Ishida Y; Fujiwara Y; Wakiyama S; Gocho T; Ito R; lida T; Suzuki F; Furukawa K; Haruki K; Misawa T; Yanaga K
Hepatogastroenterology; 2013 Oct; 60(127):1746-8. PubMed ID: 24634946
[TBL] [Abstract][Full Text] [Related]
47. The Bcl-2 and TGF-beta1 levels in patients with chronic hepatitis C, liver cirrhosis and hepatocellular carcinoma.
Ali MA; Koura BA; el-Mashad N; Zaghloul MH
Egypt J Immunol; 2004; 11(1):83-90. PubMed ID: 15724390
[TBL] [Abstract][Full Text] [Related]
48. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.
Mazziotti G; Sorvillo F; Morisco F; Carbone A; Rotondi M; Stornaiuolo G; Precone DF; Cioffi M; Gaeta GB; Caporaso N; Carella C
Cancer; 2002 Dec; 95(12):2539-45. PubMed ID: 12467068
[TBL] [Abstract][Full Text] [Related]
49. Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases.
Shirai Y; Kawata S; Tamura S; Ito N; Tsushima H; Takaishi K; Kiso S; Matsuzawa Y
Cancer; 1994 May; 73(9):2275-9. PubMed ID: 7513247
[TBL] [Abstract][Full Text] [Related]
50. Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma.
Noh CK; Kim SS; Kim DK; Lee HY; Cho HJ; Yoon SY; Lee GH; Hyun SA; Kim YJ; Kim HJ; Hwang JA; Ahn SJ; Shin SJ; Lee KM; Yoo BM; Cho SW; Cheong JY
Clin Biochem; 2014 Sep; 47(13-14):1257-61. PubMed ID: 24836184
[TBL] [Abstract][Full Text] [Related]
51. Serum markers for fibrosis and plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma in comparison with patients with liver cirrhosis.
Murawaki Y; Ikuta Y; Nishimura Y; Koda M; Kawasaki H
J Gastroenterol Hepatol; 1996 May; 11(5):443-50. PubMed ID: 8743916
[TBL] [Abstract][Full Text] [Related]
52. Serum Beta-2 Microglobulin: a Possible Marker for Disease Progression in Egyptian Patients with Chronic HCV Related Liver Diseases.
Ouda SM; Khairy AM; Sorour AE; Mikhail MN
Asian Pac J Cancer Prev; 2015; 16(17):7825-9. PubMed ID: 26625805
[TBL] [Abstract][Full Text] [Related]
53. No evidence for increased platelet activation in patients with hepatitis B- or C-related cirrhosis and hepatocellular carcinoma.
Alkozai EM; Porte RJ; Adelmeijer J; Zanetto A; Simioni P; Senzolo M; Lisman T
Thromb Res; 2015 Feb; 135(2):292-7. PubMed ID: 25434630
[TBL] [Abstract][Full Text] [Related]
54. Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents.
Calvaruso V; Cabibbo G; Cacciola I; Petta S; Madonia S; Bellia A; Tinè F; Distefano M; Licata A; Giannitrapani L; Prestileo T; Mazzola G; Di Rosolini MA; Larocca L; Bertino G; Digiacomo A; Benanti F; Guarneri L; Averna A; Iacobello C; Magro A; Scalisi I; Cartabellotta F; Savalli F; Barbara M; Davì A; Russello M; Scifo G; Squadrito G; Cammà C; Raimondo G; Craxì A; Di Marco V;
Gastroenterology; 2018 Aug; 155(2):411-421.e4. PubMed ID: 29655836
[TBL] [Abstract][Full Text] [Related]
55. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
[TBL] [Abstract][Full Text] [Related]
56. Chromogranin A levels in chronic liver disease and hepatocellular carcinoma.
Massironi S; Fraquelli M; Paggi S; Sangiovanni A; Conte D; Sciola V; Ciafardini C; Colombo M; Peracchi M
Dig Liver Dis; 2009 Jan; 41(1):31-5. PubMed ID: 18762462
[TBL] [Abstract][Full Text] [Related]
57. Serum levels of estrogens and testosterone in cirrhotic men with and without hepatocellular carcinoma.
Nagasue N; Ogawa Y; Yukaya H; Ohta N; Ito A
Gastroenterology; 1985 Mar; 88(3):768-72. PubMed ID: 2981753
[TBL] [Abstract][Full Text] [Related]
58. Plasma amino acid levels in patients with colorectal cancers and liver cirrhosis with hepatocellular carcinoma.
Lee JC; Chen MJ; Chang CH; Tiai YF; Lin PW; Lai HS; Wang ST
Hepatogastroenterology; 2003; 50(53):1269-73. PubMed ID: 14571716
[TBL] [Abstract][Full Text] [Related]
59. Foetal steroid binding protein and malignancy.
Forbes A
Anticancer Res; 1987; 7(5B):937-41. PubMed ID: 2829702
[TBL] [Abstract][Full Text] [Related]
60. Serum erythropoietin measurements by a one-step sandwich enzyme linked immunosorbent assay in patients with hepatocellular carcinoma and liver cirrhosis.
Sawabe Y; Iida S; Tabata Y; Yonemitsu H
Jpn J Clin Oncol; 1993 Oct; 23(5):273-7. PubMed ID: 7693989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
